Difference between revisions of "Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265)"
(Created page with "<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking...") |
|||
Line 1: | Line 1: | ||
+ | {{infobox_publicationsection}} | ||
+ | |||
<b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 1: Introduction</u></h3><p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).</p><small><b><em>Go to [[Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small> | <b>From publication:</b> "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)<br> https://doi.org/10.1080/22221751.2020.1735265<br><h3><u>Section 1: Introduction</u></h3><p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).</p><small><b><em>Go to [[Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)|next section]] in publication</em></b></small> |
Latest revision as of 19:17, 14 May 2020
From publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)
https://doi.org/10.1080/22221751.2020.1735265
Section 1: Introduction
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel type of coronavirus of beta genus that leads to an emerging infectious disease with remarkable pulmonary involvement in China since December 2019. The clinical features include fever, dry cough, shortness of breath, normal or low levels of peripheral white blood cells, and inflammatory changes on chest X-ray. China has designated SARS-CoV-2 infected pneumonia as a statutory infectious disease. To standardize the clinical diagnosis and treatment, Peking Union Medical College Hospital (PUMCH) has established a working group and formulated the following operational recommendation regarding "Diagnosis and Clinical Management of Severe Acute Respiratory Syndrome Coronavirus 2 Infection" (V2.0).
Go to next section in publication